EPPICon 2018 SPEAKERS
Aashima Gupta
Global Head - Healthcare Solutions, Google Cloud Platform at Google
Vipin Gopal
Chief Data and Analytics Officer,
Eli Lilly
Jacqueline Law
Global Head, Real World Data Science, Genentech
Ken Carson
Senior Medical Director,
Flatiron Health
Iya Khalil
Co-Founder,
GNS Healthcare
Noga Leviner
Co-Founder and CEO,
PicnicHealth
Jafar Shenasa
VP, Regulatory Affairs,
Proteus Digital Health
Jason Paragas
Director of Innovation,
Lawrence Livermore National Laboratory
Darshan Gandhi
Head of Venture Innovations,
Methodist Health System
Christine Bakan
VP, Head of Software and Bioinformatics,
Roche Molecular Solutions
Sanjay Joshi
Chief of Technology, Healthcare and Life Sciences,
H2O.ai
Raj Harapanahalli
VP, Head of Software Center of Excellence, Diagnostics Information Solutions, Roche
Mamatha Shekar
Director, Biomedical Informatics,
Illumina
Ted Driscoll
Managing Partner,
DigitalDx Ventures
Neil Kumar
CEO and Founder,
BridgeBio
Radhika Iyengar
Founding Partner,
StarChain Ventures
Faz K. Bashi
Investor
Abhijit Thatte
VP, Artificial Intelligence,
Aricent
Serafim Batzoglou
VP, Applied and computational Biology,
Illumina
Gracie Lieberman
Director of Regulatory Policy,
Genentech
Girish Muckai
VP, Business Development & Strategy,
Passage AI
Breakfast And Networking
8:30AM - 9AM
Welcome Address
9AM - 9:15AM
Ashutosh Shastry, President, EPPIC Global
Opening Keynote
9:15AM - 9:45AM
Neil Kumar, CEO and Founder, BridgeBio
Fireside chat: AI and big data in Clinical Development
9.45AM - 10.45AM
- Vipin Gopal, Chief Data and Analytics Officer, Eli Lilly
- Sanjay Joshi, CTO, H20.ai
- Jafar Shenasa, VP, Regulatory Affairs, Proteus Digital Health
- Jason Paragas, Director of Innovation, Lawrence Livermore National Laboratory
- Abhijit Thatte, VP, Artificial Intelligence, Aricent
Break
10:45AM - 11AM
Real world data driven drug development and treatments
11AM - 12:15PM
- Jacqueline Law, Global Head, Real World Data Science, Genentech
- Ken Carson, Senior Medical Director, Flatiron Health
- Iya Khalil, Co-Founder, GNS Healthcare
- Noga Leviner, Co-Founder and CEO, Picnic Health
- Gracie Lieberman, Director of Regulatory Policy, Genentech
Lunch (Networking open)
12:15PM - 1:15PM
Conference Co-Chair Remarks
1:15PM - 1:30PM
Keynote: Genomics and Personalized Medicine
1:30PM - 2PM
Christine (Chris) Bakan, VP, Head of software and bioinformatics at Roche Sequencing Solutions
Digital health and clinical decision support
2PM - 3:15PM
- Darshan Gandhi, Heme/Oncologist, Head of Venture Innovations, Methodist Health System
- Mamatha Shekar, Director, Biomedical Informatics, Illumina
- Aashima Gupta, Global Head - Healthcare Solutions, Google Cloud Platform at Google
- Raj Harapanahalli, VP, Head of Software Center of Excellence, Diagnostics Information Solutions, Roche
Break
3:15PM - 3:30PM
Speed Pitch
3:30PM - 4:30PM
- Ted Driscoll, Managing Partner, DigitalDx Ventures
- Radhika Iyengar, Founding Partner, StarChain Ventures
- Faz K. Bashi, Investor
Closing Keynote
4:30PM - 5PM
- Serafim Batzoglou, VP, Applied and computational Biology, Illumina
Reception 5PM Onwards
"
VC and audience feedback at EPPICon Speed Pitch helped me update the pitch for our company. I was able to connect with lawyers and a CMC consultant, which was very helpful in rounding out the company and helping us close a $12M round later in the year
"
Pradeep Fernandes, Co-founder and CEO, Stealth mode start-up
Pitch your idea to our VC panel at EPPICon 2018!
Who Should Attend
Stakeholders empowering the entire health eco system through technology
Stakeholders
- Innovators
- Researchers
- Enterpreneurs
- Investors
- Payers
- Providers
- Employers
- Regulators
- Policymakers
- Retailers
- Consultants
Health Eco System
- Pharma
- Biotech
- Diagnostics
- Devices
- Clinical decision support
Technology
- Digital health solutions through use of big data
- Analytics
- AI
- Machine learning
EPPICon 2018 SPONSORS
EPPICon 2018 AFFILIATES
EPPICon 2018 CO-CHAIRS
Details
RAVI SRINIVASAN, PhD
Cofounder & CEO, OncoNano Medicine
Dr. Ravi Srinivasan is a seasoned healthcare executive, serial entrepreneur and scientist. He is the Cofounder and CEO of OncoNano Medicine, a clinical stage company developing therapeutic and imaging products targeting pH disorders in diseases such as cancer. He has previously founded StemPar Sciences, an oncology company, and StrataGent Life Sciences, a dermatology company. Ravi is an inventor in over 50 patents and has developed award winning products such as the Microjet “patch-pump” for delivering injectables like insulin painlessly through the skin (Edison award 2010). He has also served in senior executive, product development and manufacturing roles in silicon valley healthcare companies including SEA Medical, Corium, and ForSight V5. Dr. Srinivasan received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a B.Tech. from IIT Mumbai.
RAVI SRINIVASAN, PhD
CEO, OncoNano
CEO, OncoNano
Details
RAVI SRINIVASAN, PhD
Cofounder & CEO, OncoNano Medicine
Dr. Ravi Srinivasan is a seasoned healthcare executive, serial entrepreneur and scientist. He is the Cofounder and CEO of OncoNano Medicine, a clinical stage company developing therapeutic and imaging products targeting pH disorders in diseases such as cancer. He has previously founded StemPar Sciences, an oncology company, and StrataGent Life Sciences, a dermatology company. Ravi is an inventor in over 50 patents and has developed award winning products such as the Microjet “patch-pump” for delivering injectables like insulin painlessly through the skin (Edison award 2010). He has also served in senior executive, product development and manufacturing roles in silicon valley healthcare companies including SEA Medical, Corium, and ForSight V5. Dr. Srinivasan received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a B.Tech. from IIT Mumbai.
Details
ASHUTOSH SHASTRY, PhD
President, EPPIC
CTO, Evanostics
Dr. Ashutosh Shastry is the Chief Technology Officer at Evanostics – a medical diagnostics company focused on developing products that re-imagine drug testing and helping resolve the raging opioid crisis in the US. Dr. Shastry has over 15 years of experience developing biosensors and multidisciplinary teams, medical devices and platforms for drug delivery and diagnostics. Utilizing his deep experience with microsystems engineering, Dr. Shastry currently leads the product and technology development for the Evanostics point-of-care detection system. Prior to joining Evanostics, Dr. Shastry served as Vice President R&D at iNDx LifeCare, and as the Director of Engineering at Corium International, Inc. At Corium, he led the technology development and scalable pilot scale manufacturing of a dissolvable microneedles patch that is past Phase IIa. He also led the development of a next generation infusion pump which received an Edison Award in the category of “Science & Medical Device Game Changers.” Earlier, at the University of Washington, Dr. Shastry initiated research on super-hydrophobic surfaces for droplet microfluidics. Dr. Shastry has a PhD in Biomedical Engineering, and MS and BS degrees in Chemical Engineering from the Indian Institute of Technology in Mumbai where he initiated BioMEMS research collaborating with Cancer Research Institute. He has authored numerous publications and has over fifteen patents. He serves on the Industrial Advisory Board for UCLA’s Bioengineering Department, is a member of the National Institute of Health Review Panel for Allergy and Infectious Diseases, and the National Science Foundation SBIR Review Panel for Biomedical Technologies and serves on the Editorial Board of Journal of Robotics and Mechanical Engineering Research.
ASHUTOSH SHASTRY, PhDCTO, Evanostics
Details
ASHUTOSH SHASTRY, PhD
President, EPPIC
CTO, Evanostics
Dr. Ashutosh Shastry is the Chief Technology Officer at Evanostics – a medical diagnostics company focused on developing products that re-imagine drug testing and helping resolve the raging opioid crisis in the US. Dr. Shastry has over 15 years of experience developing biosensors and multidisciplinary teams, medical devices and platforms for drug delivery and diagnostics. Utilizing his deep experience with microsystems engineering, Dr. Shastry currently leads the product and technology development for the Evanostics point-of-care detection system. Prior to joining Evanostics, Dr. Shastry served as Vice President R&D at iNDx LifeCare, and as the Director of Engineering at Corium International, Inc. At Corium, he led the technology development and scalable pilot scale manufacturing of a dissolvable microneedles patch that is past Phase IIa. He also led the development of a next generation infusion pump which received an Edison Award in the category of “Science & Medical Device Game Changers.” Earlier, at the University of Washington, Dr. Shastry initiated research on super-hydrophobic surfaces for droplet microfluidics. Dr. Shastry has a PhD in Biomedical Engineering, and MS and BS degrees in Chemical Engineering from the Indian Institute of Technology in Mumbai where he initiated BioMEMS research collaborating with Cancer Research Institute. He has authored numerous publications and has over fifteen patents. He serves on the Industrial Advisory Board for UCLA’s Bioengineering Department, is a member of the National Institute of Health Review Panel for Allergy and Infectious Diseases, and the National Science Foundation SBIR Review Panel for Biomedical Technologies and serves on the Editorial Board of Journal of Robotics and Mechanical Engineering Research.
